For lab managers overseeing drug discovery and disease research, maintaining accurate, scalable, and efficient tissue modeling systems is critical. MIMETAS' latest innovation, OrganoPlate UniFlow (UF), introduces unidirectional, gravity-driven flow, eliminating the need for pumps while enhancing biological relevance.
Unveiled at SLAS 2025, this platform supports up to 512 tissue models simultaneously, reducing operational complexity while ensuring high-throughput screening capabilities. It seamlessly integrates with standard liquid handling and imaging equipment, making it a cost-effective, scalable solution for labs focused on cardiovascular, oncological, and immunological research.
Why lab managers will benefit from OrganoPlate UF:
- Pump-free design reduces maintenance and simplifies operation.
- Unidirectional flow improves model accuracy for more reliable data.
- High scalability supports large-scale experiments with up to 512 chips.
- Extended culture stability enables long-term studies of chronic diseases.
- Compatible with standard lab automation for seamless workflow integration.
“The MIMETAS OrganoPlate has led the field in microphysiological cell culture for over 12 years,” said Bas Trietsch, MIMETAS co-founder. “With UniFlow, we’ve achieved unidirectional flow that mimics blood circulation while maintaining the ease of use, compatibility, and throughput that make our technology exceptional.”
OrganoPlate UF is already integrated into models for liver, lung, brain, vasculature, and tumors, supporting immunology, oncology, cardiovascular, and metabolic disease studies.
This article has been sourced from a press release and may include content created or refined using AI tools and verified by our editorial team. For the full press release click here
